Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Michael Feher"'
Autor:
Bernardo Meza-Torres, Anna Forbes, William Elson, Debasish Kar, Gavin Jamie, William Hinton, Xuejuan Fan, Rachel Byford, Michael Feher, Martin Whyte, Mark Joy, Simon de Lusignan
Publikováno v:
JMIR Research Protocols, Vol 12, p e51861 (2023)
BackgroundHepatitis A outbreaks in the United Kingdom are uncommon. Most people develop mild to moderate symptoms that resolve, without sequelae, within months. However, in high-risk groups, including those with underlying chronic liver disease (CLD)
Externí odkaz:
https://doaj.org/article/47c132f19f2e47419cc7e750e3b616f3
Autor:
Debasish Kar, Aya El-Wazir, Gayathri Delanerolle, Anna Forbes, James P. Sheppard, Mintu Nath, Mark Joy, Nicholas Cole, J. Ranjit Arnold, Andrew Lee, Michael Feher, Melanie J. Davies, Kamlesh Khunti, Simon de Lusignan, Elizabeth Goyder
Publikováno v:
EClinicalMedicine, Vol 51, Iss , Pp 101544- (2022)
Summary: Background: Smoking is attributed to both micro- and macrovascular complications at any stage of metabolic deregulation including prediabetes. Current global diabetes prevention programmes appear to be glucocentric, and do not fully acknowle
Externí odkaz:
https://doaj.org/article/9ad9f0f72d3744b9b838a663fc6b4182
Autor:
Nikhil Mayor, Bernardo Meza-Torres, Cecilia Okusi, Gayathri Delanerolle, Martin Chapman, Wenjuan Wang, Sneha Anand, Michael Feher, Jack Macartney, Rachel Byford, Mark Joy, Piers Gatenby, Vasa Curcin, Trisha Greenhalgh, Brendan Delaney, Simon de Lusignan
Publikováno v:
JMIR Public Health and Surveillance, Vol 8, Iss 8, p e36989 (2022)
BackgroundFollowing COVID-19, up to 40% of people have ongoing health problems, referred to as postacute COVID-19 or long COVID (LC). LC varies from a single persisting symptom to a complex multisystem disease. Research has flagged that this conditio
Externí odkaz:
https://doaj.org/article/d82ab59ee00a4c9da55a350329979595
Autor:
Michael Feher, William Hinton, Anna Forbes, Neil Munro, Mark Joy, David Wheeler, Simon de Lusignan
Publikováno v:
JMIR Research Protocols, Vol 11, Iss 7, p e34206 (2022)
BackgroundSodium-glucose cotransporter-2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) are both considered to be part of standard care in the management of glycemia in type 2 diabetes. Recent trial evidence has indicat
Externí odkaz:
https://doaj.org/article/a0205d5010e644f6bbbdb05718603378
Autor:
Mekha Mathew, Jeremy van Vlymen, Bernardo Meza-Torres, William Hinton, Gayathri Delanerolle, Ivelina Yonova, Michael Feher, Xuejuan Fan, Harshana Liyanage, Mark Joy, Fabrizio Carinci, Simon de Lusignan
Publikováno v:
JMIR Research Protocols, Vol 11, Iss 4, p e35971 (2022)
BackgroundSocial distancing and other nonpharmaceutical interventions to reduce the spread of COVID-19 infection in the United Kingdom have led to substantial changes in delivering ongoing care for patients with chronic conditions, including type 2 d
Externí odkaz:
https://doaj.org/article/885d84b8fd904f2287b2bd69c3314cca
Autor:
Bernardo Meza-Torres, Scott G. Cunningham, Christian Heiss, Mark Joy, Michael Feher, Graham P. Leese, Simon de Lusignan, Fabrizio Carinci
Publikováno v:
Journal of Diabetes Research, Vol 2022 (2022)
Aims. To compare different packages of care across care providers in Scotland on foot-related outcomes. Methods. A retrospective cohort study with primary and secondary care electronic health records from the Scottish Diabetes Registry, including 6,8
Externí odkaz:
https://doaj.org/article/e2a3e913fa4f426a91370156e850dcd5
Autor:
Simon de Lusignan, F D Richard Hobbs, Harshana Liyanage, Julian Sherlock, Filipa Ferreira, Manasa Tripathy, Christian Heiss, Michael Feher, Mark P Joy
Publikováno v:
PLoS ONE, Vol 17, Iss 9, p e0265998 (2022)
BackgroundWe investigated differences in risk of stroke, with all-cause mortality as a competing risk, in people newly diagnosed with atrial fibrillation (AF) who were commenced on either direct oral anticoagulants (DOACs) or warfarin treatment.Metho
Externí odkaz:
https://doaj.org/article/9ea18b8a8cde43649359fad26c115128
Autor:
Simon de Lusignan, William Hinton, Emmanouela Konstantara, Neil Munro, Martin Whyte, Julie Mount, Michael Feher
Publikováno v:
BMC Health Services Research, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background In the UK, type 2 diabetes mellitus (T2D) is largely managed in primary care. Delay in the intensification to injectable therapy, a form of clinical inertia, is associated with worse glycaemic control. UK general practice is highl
Externí odkaz:
https://doaj.org/article/edfa4efd6cc847bcab367f5fd3e0d9ed
Autor:
Mariangela Gaudio, Nicoletta Dozio, Michael Feher, Marina Scavini, Amelia Caretto, Mark Joy, Jeremy Van Vlymer, William Hinton, Simon de Lusignan
Publikováno v:
Frontiers in Endocrinology, Vol 11 (2021)
AimTo describe trends in modifiable and non-modifiable unfavorable factors affecting pregnancy outcomes, over time (years 2004–2017), in women with diabetes of childbearing age from an English primary care perspective.MethodsWe identified women wit
Externí odkaz:
https://doaj.org/article/c9cae15a17ff44f59a9a9427d4cdee55
Autor:
Harshana Liyanage, Simon de Lusignan, Filipa Ferreira, Richard Hobbs, Julian Sherlock, Neil Munro, Michael Feher
Publikováno v:
BMJ Health & Care Informatics, Vol 27, Iss 3 (2020)
Background Atrial fibrillation (AF) is a common cardiac arrhythmia which is a major risk factor for stroke, transient ischaemic attacks and increased mortality. Primary care management of AF can significantly reduce these risks. We carried out an eva
Externí odkaz:
https://doaj.org/article/87c77c72766146af8c1632a6a936a826